Efficacy and Safety of Inhaled NC-107 As Compared to Placebo After 4 Weeks of Treatment in Patients with Anxiety
Clinical trial NCT06656806 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06656806
- Sponsor
- Trinity Hypertension & Metabolic Research Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-01
- Primary completion
- 2025-05-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.